India's Cadila Healthcare starts producing COVID-19 vaccine candidate

India's Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year. "We have just started producing doses," Sharvil Patel said in a Microsoft Teams interview on Friday. Das; Editing by Catherine Evans)

India's Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.

"We have just started producing doses," Sharvil Patel said in a Microsoft Teams interview on Friday. "But it is not meaningfully large." (Writing by Krishna N. Das; Editing by Catherine Evans)